Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Teicher

Showing results (31-40 of 417) with videos related to

Pageof 42
Sort By:
Biochemical Pharmacology|October 6, 2010
Antiangiogenic agents and targets: A perspectiveBeverly A Teicher
Biochemical Pharmacology|December 7, 2007
Next generation topoisomerase I inhibitors: Rationale and biomarker strategiesBeverly A Teicher
Oncology Reports|July 4, 2013
Perspective: Opportunities in recalcitrant, rare and neglected tumorsBeverly A Teicher
Expert Opinion on Drug Discovery|March 14, 2013
Human tumor xenografts and mouse models of human tumors: re-discovering the modelsBeverly A Teicher
Biochemical Pharmacology|October 5, 2013
Targets in small cell lung cancerBeverly A Teicher
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|November 4, 2005
Tumor models for preclinical development of targeted agentsBeverly A Teicher
Cancer Metastasis Reviews|June 1, 1994
Hypoxia and drug resistanceB A Teicher
Current Cancer Drug Targets|December 23, 2009
Antibody-drug conjugate targetsB A Teicher
Toxicologic Pathology|December 23, 2008
In vivo/ex vivo and in situ assays used in cancer research: a brief reviewBeverly A Teicher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Transforming growth factor-beta and the immune response to malignant diseaseBeverly A Teicher
Pageof 42

Showing results (31-40 of 417) with videos related to

Sort By:
Pageof 42
Biochemical Pharmacology|October 6, 2010
Antiangiogenic agents and targets: A perspectiveBeverly A Teicher
Biochemical Pharmacology|December 7, 2007
Next generation topoisomerase I inhibitors: Rationale and biomarker strategiesBeverly A Teicher
Oncology Reports|July 4, 2013
Perspective: Opportunities in recalcitrant, rare and neglected tumorsBeverly A Teicher
Expert Opinion on Drug Discovery|March 14, 2013
Human tumor xenografts and mouse models of human tumors: re-discovering the modelsBeverly A Teicher
Biochemical Pharmacology|October 5, 2013
Targets in small cell lung cancerBeverly A Teicher
Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progres Des Recherches Pharmaceutiques|November 4, 2005
Tumor models for preclinical development of targeted agentsBeverly A Teicher
Cancer Metastasis Reviews|June 1, 1994
Hypoxia and drug resistanceB A Teicher
Current Cancer Drug Targets|December 23, 2009
Antibody-drug conjugate targetsB A Teicher
Toxicologic Pathology|December 23, 2008
In vivo/ex vivo and in situ assays used in cancer research: a brief reviewBeverly A Teicher
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Transforming growth factor-beta and the immune response to malignant diseaseBeverly A Teicher
Pageof 42